Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1986-04-28
1989-02-28
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514825, 536 551, A61K 31715
Patent
active
048085766
ABSTRACT:
The present disclosure is concerned with the discovery that hyaluronic acid, an agent well known to reduce the sequelae of trauma in mammalian joint tissue when applied directly to the traumatized tissue, will be carried to such traumatized tissue by the mammal's natural processes if applied at a site remote from the traumatized tissue. Thus, hyaluronic acid, in any therapeutically acceptable form, can be administered by the typical remote routes including intravenous, intramuscular, subcutaneous and topical.
This makes the utilization of hyaluronic acid much more convenient and attractive. For instance the treatment of arthritis in horse or human joints with hyaluronic acid no longer requires more difficult intra articular injections.
REFERENCES:
patent: 4055660 (1977-10-01), Meierhenry
patent: 4141973 (1979-02-01), Balazs
patent: 4272522 (1981-06-01), Balazs
patent: 4296104 (1981-10-01), Herschler
patent: 4427649 (1984-01-01), Dingle et al.
patent: 4517295 (1985-05-01), Bracke et al.
patent: 4521406 (1985-06-01), Kawamura et al.
Chemical Abstracts, Band 102, Nr.11, Mar. 18, 1985, Nr. 89817, Columbus, Ohio, "Studies on Analgesic and Anti-Inflammatory Effects of Sodium Hyaluronate".
Chemical Abstracts, Band 106, Nr.7, Feb. 16, 1987, Nr. 4352Ou, Columbus, Ohio, "Topical Treatment of Experimental Skin Lesions in Rats".
Preliminary Clinical Assessment of NaHyaluronate Injection Into Human Arthritic Joints, by Peyron et al, vol. 22, No. 8, pp. 731-736, Oct., 1974.
Decreased Granulation Tissue Reaction After Installment of Hyaluronic Acid, by Rydell, pp. 307-311, vol. 41, of Acta Orthop Scandinav.
Letter in Veterinary Medicine, pp. 446-447, Apr. 1984 Issue.
Influence of a Glycosaminoglycan Polysulfate on Iysosomal Enzyme Release from Human Polymorphonuclear Leukocytes, vol. 41, pp. 50-53, 1982.
Polysulfated Glycosaminoglycan: A New Intra-Articular Treatment for Equine Lameness, Vet. Medicine, pp. 811-816, Jun. 1984.
Clinical Orthopaedics, pp. 25-32, Oct., 1971, No. 80, by Rydel et al, "Effect of Intra-Articular Injection of Hyaluronic Acid on Clinical Symptoms".
Influences of Sulfated Glycosaminoglycans on Biosynthesis of Hyaluronic Acid in Rabbit Knee Synovial Membrane, by Nishikawa, pp. 146-153, Jul. 1985, vo. 240.
Vergleich von Glykosaminoglykanpolysulfat und Physiologischer Kochsalzlosung bei Arthorosen Grober Gelenke, pp. 223-228, vol. 42, Jul. 1983.
Die Tierexperimentelle Gonartrose der Ratte und Ihre Therapie mit Glykoaminoglykan Polysulfat, pp. 100-107, vol. 44, 1985.
Brown Karen K.
Greene Nathan D.
Mozier John O.
Schultz Richard H.
Wollen Terry H.
Gil Joseph C.
Griffin Ronald W.
Harsh Gene
Mobay Corporation
Whalen Lyndanne M.
LandOfFree
Remote administration of hyaluronic acid to mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Remote administration of hyaluronic acid to mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remote administration of hyaluronic acid to mammals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1367103